Upgrade to SI Premium - Free Trial

Piper Sandler Reiterates Neutral Rating on Medtronic, Inc. (MDT)

August 10, 2026 8:48 AM
Piper Sandler analyst Matt O'Brien reiterated a Neutral rating and $85.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments